tm logo
TAVEREN THERAPEUTICS
Live/Pending
RESPONSE AFTER NON-FINAL ACTION - ENTERED

final action

on 18 Nov 2024

Last Applicant/ Owned by

CZ-160 00 Praha 6

CZ

Serial Number

79383216 filed on 12th Sep 2023

Registration Number

N/A

Correspondent Address

Jason J. Mazur

Jason J. Mazur ArentFox Schiff LLP

Washington, DC 20006

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

TAVEREN THERAPEUTICS

Research and development for the pharmaceutical industry; development of pharmaceutical preparations and medicines; medical research in the field of oncology; medical research in the field of neurobiology; chemical analysis; analytical laboratory services, namely, research laboratory analysis services in the field of biochemistry; biochemistry research services; chemistry services, namely, chemica Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development for the pharmaceutical industry; development of pharmaceutical preparations and medicines; medical research in the field of oncology; medical research in the field of neurobiology; chemical analysis; analytical laboratory services, namely, research laboratory analysis services in the field of biochemistry; biochemistry research services; chemistry services, namely, chemical synthesis; advisory services relating to research and development of pharmaceutical drugs; science and technology services, namely, scientific research; technological consultancy in the field of treatment of oncological diseases; scientific laboratory services; conducting early evaluations in the field of new pharmaceuticals


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical drugs for treatment of oncological diseases; chemical preparations for medical purposes for treatment of oncological diseases; diagnostic substances for medical use; chemical preparations for pharmaceutical purposes for treatment of oncological diseases; adjuvants for medical purposes; diagnostic preparations for medical purposes; pharmaceutical compositions for treatment of oncological diseases; biological preparations for use in cell cultures for medical purposes.


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79383216

Mark Type

No Service Mark

Attorney Docket Number

No 046036.00002

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
18th Nov 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
18th Nov 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
18th Nov 2024TEAS/EMAIL CORRESPONDENCE ENTERED
23rd Jun 2024REFUSAL PROCESSED BY IB
06th Jun 2024REFUSAL PROCESSED BY MPU
06th Jun 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04th Jun 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
16th May 2024NON-FINAL ACTION WRITTEN
07th May 2024ASSIGNED TO EXAMINER
21st Nov 2023APPLICATION FILING RECEIPT MAILED